These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Anti-arrhythmic effectiveness of isoptin in ischemic heart disease in the middle-aged and elderly]. Korkushko OV; Sarkisov KG; Butenko AG Vrach Delo; 1980 Jan; (1):30-5. PubMed ID: 7376578 [No Abstract] [Full Text] [Related]
24. [Diagnostic difficulties and the characteristics of the therapeutic approach in combined bronchial asthma and ischemic heart disease]. Sinopal'nikov AI; Alekseev VG; Pechatnikov LM Voen Med Zh; 1986 Nov; (11):24-8. PubMed ID: 3824972 [No Abstract] [Full Text] [Related]
25. Oxprenolol in the treatment of anxiety due to environmental stress. McMillin WP Am J Psychiatry; 1975 Sep; 132(9):965-6. PubMed ID: 1155635 [TBL] [Abstract][Full Text] [Related]
26. [Clinical use of digoxin]. Zeme D Cardiol Prat; 1970 Aug; 21(4):255-67. PubMed ID: 5495417 [No Abstract] [Full Text] [Related]
27. [Clinical study of the effects of creatinolo-O-phosphate in heart diseases]. Melloni G; Camerini L; Fassini G; Saurgnani E; Marangoni R Minerva Med; 1968 Jun; 59(45):2600-13. PubMed ID: 5663709 [No Abstract] [Full Text] [Related]
28. [The anti-arrhythmic effect of L-carnitine in subjects with ischemic cardiopathy]. Schiavoni G; Lucente M; Di Folca A; Alessandri N; Mongiardo R; Manzoli U Clin Ter; 1981 Feb; 96(3):263-70. PubMed ID: 7307446 [No Abstract] [Full Text] [Related]
29. [On the clinical use of proscillaridin A (Sandoscill)]. Straube W Med Welt; 1967 Sep; 39():2312-4. PubMed ID: 5629431 [No Abstract] [Full Text] [Related]
30. [International symposium. Magnesium in heart rhythm disorders and coronary disease--experience of the CAST study. Montreux, 19 April 1991]. Internist (Berl); 1991; 32(7 Suppl [MAGNESIU]):1-8. PubMed ID: 1684354 [No Abstract] [Full Text] [Related]
31. [Prevention of sudden death in ischemic heart disease]. Tsolov Ts Vutr Boles; 1980; 19(6):14-21. PubMed ID: 6111160 [No Abstract] [Full Text] [Related]
33. [Clinical experience with the anti-arrhythmic activity of bretylium tosylate]. Calabrese P; Rizzon P Boll Soc Ital Cardiol; 1972; 17(7):407-12. PubMed ID: 4650835 [No Abstract] [Full Text] [Related]
34. [Clinical and experimental studies on the effects and duration of action of N-n-propyl-ajmalinium-hydrogentartrate in cardiac arrhythmia]. Koch R Arzneimittelforschung; 1972 Dec; 22(12):2079-84. PubMed ID: 4679174 [No Abstract] [Full Text] [Related]
35. [Di-mono-chloroacetyl-ajmaline in the treatment of disorders of cardiac rhythm]. Bucur V; Enescu R; Sirbulescu R; Pompilian P Med Interna (Bucur); 1969 Jan; 21(1):47-58. PubMed ID: 5779664 [No Abstract] [Full Text] [Related]
36. [Action of propranolol, beta-adrenergic blocking agent, on disorders of cardiac rhythm]. Sánchez A; Cárdenas M; Shapiro M Arch Inst Cardiol Mex; 1967; 37(1):47-62. PubMed ID: 6058090 [No Abstract] [Full Text] [Related]
37. [The antiarrhythmic and coronary-dilating properties of verapamil in patients ith ischemic heart disease]. Votcal BE; Lozinskij LG; Goldberg VA; Venediktova MG; Gribova OA Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1281+. PubMed ID: 5312386 [No Abstract] [Full Text] [Related]
38. [Clinical use of a new cardioactive glycoside: proscillaridin A. Case studies]. Pagliara R Minerva Med; 1967 Dec; 58(96):4296-301. PubMed ID: 6081717 [No Abstract] [Full Text] [Related]
39. [Clinical use of a new cardioactive glycoside: proscillaridin A]. Tronconi L; Storti D Minerva Med; 1966 May; 57(43 Suppl):2011-7. PubMed ID: 5944829 [No Abstract] [Full Text] [Related]